Hikma Pharmaceuticals PLC (HIK.L)
GBp 1869.0
(2.13%)
GBp 1869.0
(2.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.87 Billion | 2.51 Billion | 2.55 Billion | 2.34 Billion | 2.2 Billion | 2.07 Billion |
| Cost of Revenue | 1.48 Billion | 1.25 Billion | 1.25 Billion | 1.12 Billion | 1.1 Billion | 1.06 Billion |
| Gross Profit | 1.39 Billion | 1.26 Billion | 1.3 Billion | 1.21 Billion | 1.09 Billion | 1 Billion |
| Operating Expenses | 1.04 Billion | 976 Million | 715 Million | 621 Million | 578 Million | 673 Million |
| Selling, General and Administrative Expenses | 632 Million | 509 Million | 488 Million | 506 Million | 487 Million | 467 Million |
| Research and Development Expenses | 149 Million | 144 Million | 143 Million | 137 Million | 150 Million | 147 Million |
| Other Expenses | 259 Million | - | - | - | - | - |
| Cost and Expenses | 2.5 Billion | 2.22 Billion | 1.96 Billion | 1.74 Billion | 1.68 Billion | 1.73 Billion |
| Operating Income | 367 Million | 591 Million | 634 Million | 540 Million | 486 Million | 428 Million |
| Interest Expense | 90 Million | 77 Million | 56 Million | 56 Million | 67 Million | 80 Million |
| Income Tax Expense | 89 Million | 42 Million | 124 Million | 128 Million | 4 Million | 8 Million |
| Earnings before Tax | 281 Million | 233 Million | 544 Million | 558 Million | 491 Million | 293 Million |
| Net Income | 190 Million | 188 Million | 421 Million | 431 Million | 486 Million | 282 Million |
| Earnings Per Share Basic | 0.85 | 0.84 | 1.82 | 1.83 | 2.01 | 1.17 |
| Earnings Per Share Diluted | 0.85 | 0.84 | 1.81 | 1.81 | 2.00 | 1.17 |
| Weighted Average Shares Outstanding | 223.52 Million | 223.72 Million | 231 Million | 236 Million | 242 Million | 241 Million |
| Weighted Average Shares Outstanding (Diluted) | 222.36 Million | 225 Million | 233 Million | 238 Million | 243 Million | 242 Million |
| Gross Margin | 0.48 | 0.50 | 0.51 | 0.52 | 0.50 | 0.49 |
| EBIT Margin | 0.28 | 0.30 | 0.31 | 0.28 | 0.26 | 0.25 |
| Profit Margin | 0.07 | 0.07 | 0.16 | 0.18 | 0.22 | 0.14 |
| EBITDA | 791 Million | 485 Million | 744 Million | 654 Million | 584 Million | 527 Million |
| Earnings Before Tax Margin | 0.13 | 0.23 | 0.25 | 0.23 | 0.22 | 0.21 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.56 Billion | 1.44 Billion | 2.87 Billion | 1.42 Billion | 2.51 Billion | 1.3 Billion |
| Cost of Revenue | 813 Million | 756 Million | 1.48 Billion | 712 Million | 1.25 Billion | 662 Million |
| Gross Profit | 756 Million | 692 Million | 1.39 Billion | 715 Million | 1.26 Billion | 642 Million |
| Operating Expenses | 405 Million | 588 Million | 785 Million | 472 Million | 976 Million | 600 Million |
| Selling, General and Administrative Expenses | 280 Million | 371 Million | - | 261 Million | - | 345 Million |
| Research and Development Expenses | 61 Million | 85 Million | - | 64 Million | - | 75 Million |
| Other Expenses | 64 Million | - | - | - | - | - |
| Cost and Expenses | 1.21 Billion | 1.34 Billion | 2.27 Billion | 1.18 Billion | 2.22 Billion | 1.26 Billion |
| Operating Income | 351 Million | 310 Million | 367 Million | 309 Million | 591 Million | 202 Million |
| Interest Expense | - | - | 90 Million | - | 77 Million | - |
| Income Tax Expense | 59 Million | 18 Million | 89 Million | 71 Million | 42 Million | 1 Million |
| Earnings before Tax | 288 Million | 79 Million | 281 Million | 202 Million | 233 Million | 18 Million |
| Net Income | 226 Million | 59 Million | 190 Million | 131 Million | 188 Million | 15 Million |
| Earnings Per Share Basic | 1.01 | 0.26 | - | 0.59 | - | 0.07 |
| Earnings Per Share Diluted | 1.01 | 0.26 | - | 0.59 | - | 0.07 |
| Weighted Average Shares Outstanding | 223.76 Million | 226.44 Million | 220.86 Million | 222.03 Million | 223.72 Million | 220.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 223.76 Million | 222.73 Million | 222.36 Million | 222.03 Million | 225 Million | 221.81 Million |
| Gross Margin | 0.48 | 0.48 | 0.48 | 0.50 | 0.50 | 0.49 |
| EBIT Margin | 0.32 | 0.24 | - | 0.31 | - | 0.22 |
| Profit Margin | 0.14 | 0.04 | 0.07 | 0.09 | 0.07 | 0.01 |
| EBITDA | 499 Million | 345 Million | - | 446 Million | - | 284 Million |
| Earnings Before Tax Margin | 0.22 | 0.21 | 0.13 | 0.22 | 0.23 | 0.15 |
300115
GLASF
9562
NIOIF
MCT
TGL